INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 291 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $253,633 | -50.1% | 11,333 | -38.7% | 0.04% | -44.6% |
| Q1 2024 | $508,220 | +61.0% | 18,474 | +78.4% | 0.06% | +6.6% |
| Q4 2023 | $315,724 | +341.2% | 10,355 | +357.6% | 0.06% | +190.5% |
| Q3 2023 | $71,556 | +51.9% | 2,263 | +95.9% | 0.02% | +40.0% |
| Q2 2023 | $47,101 | +6.0% | 1,155 | -3.1% | 0.02% | 0.0% |
| Q1 2023 | $44,426 | +33.5% | 1,192 | +24.9% | 0.02% | +15.4% |
| Q4 2022 | $33,285 | -30.7% | 954 | +10.2% | 0.01% | -35.0% |
| Q3 2022 | $48,000 | +500.0% | 866 | +462.3% | 0.02% | +566.7% |
| Q2 2022 | $8,000 | -27.3% | 154 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $11,000 | -38.9% | 154 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $18,000 | – | 154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |